INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc. – AI

NEW YORK CITY, NY / ACCESS Newswire / February 28, 2026 / Pomerantz LLP is investigating claims on behalf of investors of C3.ai, Inc. ("C3" or the "Company") (NYSE:AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether C3and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On February 25, 2026, C3 announced its financial results for the fiscal third quarter ended January 31, 2026, which fell significantly short of consensus estimates. C3 also announced a restructuring plan that "includes a 26% reduction in its global workforce," "in connection with [which], the Company estimates that it will incur approximately $10.0 million to $12.0 million in pre-tax restructuring charges in the fourth quarter of fiscal year 2026, consisting of cash expenditures related to severance, other one-time termination benefits, and non-cash expenditures related to stock-based compensation."

On this news, C3’s stock price fell $1.91 per share, or 18.53%, to close at $8.40 per share on February 26, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

SOURCE: Pomerantz LLP

View the original press release on ACCESS Newswire

comtex tracking

COMTEX_474396060/2457/2026-02-28T10:03:01

Scroll to Top